Skip to main content

Report

New innovative new treatments for hemophilia B, RSV and COPD

Cutting-edge research in gene therapy, mRNA editing and blood enzymes pays off with powerful new advances for these drug classes. 

Novel treatments, increased choice and competition

This edition of the Drug Pipeline Insights Report showcases:

  • Second gene therapy for hemophilia B
  • Nontraditional RSV vaccine
  • Maintenance treatment for COPD

Related healthcare insights

View all

Article

The latest PBM regulations: Summer 2024

Get your guide to the evolving health care regulatory landscape and see what’s coming as lawmakers debate 600+ new bills impacting PBMs.

Article

Empowering clients with choice and transparency

Helping make prescription drugs more affordable for plan sponsors and the members we serve is a universal focus.

Article

Biosimilars to save billions in this decade

Prices for popular brand-name biologics drop up to 60% with generic-equivalent biosimilars.